Projects per year
Personal profile
Education
- 2011 Dphil Clinical Pharmacology Department, University of Oxford
- 2005 M.S., Department of Biochemistry and Molecular Cell Biology, Taipei Medical University
- 2003 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2020- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2020- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2019- Director, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2017-2020 Associate Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2017-2020 Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014-2017 Assistant Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2013-2017 Assistant Professor, Department of Clinical Pharmacy, Taipei Medical University
Research Interests
- Molecular mechanisms of tumorigenesis and translational medicine
- Toxicology and development of nanomaterials as drug delivery platform
- Protein post-translational modifications in cancer regulation
Fingerprint
Dive into the research topics where Er-Chieh Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
HDAC/LSD1雙效抑制劑於大腸癌治療之新藥開發與機轉研究
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
有機/無機混成奈米複合材料發展智慧型藥物傳輸系統以治療p53失效腫瘤之探討與評估
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討粒線體因子C20orf7在大腸癌進程中對化療藥物抗藥性及上皮細胞間質轉化作用EMT之調控機轉及大腸癌合併治療策略研究
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討趨化因子CCR6於大腸癌5-FU抗藥性的調控機轉及合併治療研究
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
官能性奈米鑽石複合金屬氧化物於對抗自由基及抗老化之應用性研究
1/1/20 → 12/31/20
Project: A - Government Institution › d - Ministry of Education
-
A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation
Lee, H. Y., Tang, D. W., Liu, C. Y. & Cho, E. C., Jan 25 2022, In: Chemico-Biological Interactions. 352, 109778.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Bio-Phenolic Resin Derived Porous Carbon Materials for High-Performance Lithium-Ion Capacitor
Cho, E. C., Chang-Jian, C. W., Lu, C. Z., Huang, J. H., Hsieh, T. H., Wu, N. J., Lee, K. C., Hsu, S. C. & Weng, H. C., Feb 1 2022, In: Polymers. 14, 3, 575.Research output: Contribution to journal › Article › peer-review
Open Access -
Integration of PEG and PEI with graphene quantum dots to fabricate pH-responsive nanostars for colon cancer suppression in vitro and in vivo
Lee, G. Y., Lo, P. Y., Cho, E. C., Zheng, J. H., Li, M., Huang, J. H. & Lee, K. C., Jan 2022, In: FlatChem. 31, 100320.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors
Lin, T. E., Sung, L. C., Chao, M. W., Li, M., Zheng, J. H., Sung, T. Y., Hsieh, J. H., Yang, C. R., Lee, H. Y., Cho, E. C. & Hsu, K. C., 2022, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 37, 1, p. 226-235 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Co2+-Doped BiOBrxCl1-x hierarchical microspheres display enhanced visible-light photocatalytic performance in the degradation of rhodamine B and antibiotics and the inactivation of E. coli
Cho, E-C., Chang-Jian, C-W., Huang, J-H., Lee, G-Y., Hung, W-H., Sung, M-Y., Lee, K-C., Weng, H. C., Syu, W-L., Hsiao, Y-S. & Chen, C-P., Jan 15 2021, In: Journal of Hazardous Materials. 402, p. 123457 123457.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus)